Loading...
XNASXWEL
Market cap8mUSD
Dec 26, Last price  
1.60USD
1D
1.91%
1Q
-10.61%
IPO
-99.81%
Name

XWELL Inc

Chart & Performance

D1W1MN
XNAS:XWEL chart
P/E
—
P/S
0.28
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
180.08%
Rev. gr., 5y
-9.68%
Revenues
30m
-46.18%
020,000211,000718,000369,0001,100,0001,425,00022,687,00018,974,00048,823,00050,094,00048,515,0008,385,00073,729,00055,939,00030,109,000
Net income
-28m
L-14.98%
-7,332,000-6,149,000-9,942,000-7,479,000-20,841,000-52,433,000-109,677,000-11,157,000-24,006,000-28,840,000-37,205,000-20,530,000-92,232,0003,349,000-32,629,000-27,741,000
CFO
-16m
L-33.55%
-7,296,000-4,850,000-6,361,000-5,380,000-14,468,000-23,465,000-28,382,000-2,571,000-8,441,000-12,172,000-6,566,000-113,000-25,012,00015,642,000-24,188,000-16,074,000
Earnings
May 13, 2025

Profile

XpresSpa Group, Inc., a health and wellness services company, provides spa services at airports. It operates through three segments: XpresSpa, XpresTest, and Treat. The company offers spa services, including massage, and nail and skin care, as well as spa and travel products; and retail products. It also operates wellness centers that provides COVID-19 screening and testing, and rapid testing services for other communicable diseases, such as influenza, COVID-19, RSV, Flu A&B, and seasonal flu vaccination services; and other medical diagnostic testing services. In addition, the company offers services through an integrated digital platform, and a relevant retail offering to the traveling public. As of December 31, 2021, it operated 52 spa and clinic locations in 24 airports in the United States, the Netherlands, and the United Arab Emirates. The company was formerly known as FORM Holdings Corp. and changed its name to XpresSpa Group, Inc. in January 2018. XpresSpa Group, Inc. is headquartered in New York, New York.
URL
https://www.xwell.com/
IPO date
Jun 18, 2010
Employees
363
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
30,109
-46.18%
55,939
-24.13%
73,729
779.30%
Cost of revenue
47,339
75,060
65,500
Unusual Expense (Income)
NOPBT
(17,230)
(19,121)
8,229
NOPBT Margin
11.16%
Operating Taxes
35
55
140
Tax Rate
1.70%
NOPAT
(17,265)
(19,176)
8,089
Net income
(27,741)
-14.98%
(32,629)
-1,074.29%
3,349
-103.63%
Dividends
Dividend yield
Proceeds from repurchase of equity
(22)
(23,759)
9,260
BB yield
0.30%
69.91%
-4.36%
Debt
Debt current
4,804
2,586
6,320
Long-term debt
19,786
25,628
17,744
Deferred revenue
Other long-term liabilities
Net debt
1,490
(14,081)
(82,164)
Cash flow
Cash from operating activities
(16,074)
(24,188)
15,642
CAPEX
(1,905)
(6,837)
(8,670)
Cash from investing activities
5,650
(34,843)
(6,236)
Cash from financing activities
8
(27,377)
6,349
FCF
(12,433)
(20,122)
4,288
Balance
Cash
23,050
42,191
105,506
Long term investments
50
104
722
Excess cash
21,595
39,498
102,542
Stockholders' equity
(449,766)
(419,791)
(387,371)
Invested Capital
484,233
481,274
500,527
ROIC
1.63%
ROCE
7.27%
EV
Common stock shares outstanding
4,175
4,683
5,254
Price
1.74
-76.03%
7.26
-82.03%
40.40
69.75%
Market cap
7,265
-78.62%
33,988
-83.99%
212,255
300.21%
EV
16,724
27,930
137,294
EBITDA
(13,684)
(11,848)
13,148
EV/EBITDA
10.44
Interest
321
16,127
Interest/NOPBT